- Home
- NLY vs BAX Comparison
NLY vs BAX Comparison
Compare NLY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLY
- BAX
- Stock Information
- Founded
- NLY 1996
- BAX 1931
- Country
- NLY United States
- BAX United States
- Employees
- NLY N/A
- BAX N/A
- Industry
- NLY Real Estate Investment Trusts
- BAX Medical/Dental Instruments
- Sector
- NLY Real Estate
- BAX Health Care
- Exchange
- NLY Nasdaq
- BAX Nasdaq
- Market Cap
- NLY 13.2B
- BAX 11.3B
- IPO Year
- NLY 1997
- BAX N/A
- Fundamental
- Price
- NLY $20.56
- BAX $18.75
- Analyst Decision
- NLY Buy
- BAX Hold
- Analyst Count
- NLY 9
- BAX 9
- Target Price
- NLY $21.63
- BAX $30.78
- AVG Volume (30 Days)
- NLY 6.5M
- BAX 5.4M
- Earning Date
- NLY 10-22-2025
- BAX 10-30-2025
- Dividend Yield
- NLY 13.55%
- BAX 3.03%
- EPS Growth
- NLY N/A
- BAX N/A
- EPS
- NLY 2.19
- BAX N/A
- Revenue
- NLY $1,839,003,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- NLY $347.81
- BAX $7.40
- Revenue Next Year
- NLY $2.51
- BAX $3.78
- P/E Ratio
- NLY $9.41
- BAX N/A
- Revenue Growth
- NLY 394.51
- BAX 3.60
- 52 Week Low
- NLY $16.60
- BAX $21.33
- 52 Week High
- NLY $22.45
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- NLY 43.45
- BAX 21.97
- Support Level
- NLY $20.85
- BAX $22.53
- Resistance Level
- NLY $21.22
- BAX $23.35
- Average True Range (ATR)
- NLY 0.32
- BAX 0.57
- MACD
- NLY -0.01
- BAX -0.22
- Stochastic Oscillator
- NLY 16.84
- BAX 6.37
About NLY Annaly Capital Management Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are; the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.